KERALA AYURVEDA
Back to Cashflow Statement
|
KERALA AYURVEDA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹18 Cr | ₹-1.14 Cr | ₹-13 Cr | ₹6.20 Cr | ₹0.85 Cr |
What is the latest Cash Flow from Financing Activities ratio of KERALA AYURVEDA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹18 Cr |
Mar2023 | ₹-1.14 Cr |
Mar2022 | ₹-13 Cr |
Mar2021 | ₹6.20 Cr |
Mar2020 | ₹0.85 Cr |
How is Cash Flow from Financing Activities of KERALA AYURVEDA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹18 Cr | Positive | |
Mar2023 | ₹-1.14 Cr | Negative | |
Mar2022 | ₹-13 Cr | Negative | |
Mar2021 | ₹6.20 Cr | 630.74 | |
Mar2020 | ₹0.85 Cr | - |
Compare Cash Flow from Financing Activities of peers of KERALA AYURVEDA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KERALA AYURVEDA | ₹703.9 Cr | 2.9% | 21.4% | 48.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,580.0 Cr | 0.6% | -0.4% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,069.0 Cr | -2.2% | 1.7% | 47.3% | Stock Analytics | |
CIPLA | ₹119,919.0 Cr | -0.2% | -1.4% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹115,310.0 Cr | 2.5% | 4.8% | 12.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,402.0 Cr | -2.6% | -8.1% | -4.9% | Stock Analytics |
KERALA AYURVEDA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KERALA AYURVEDA | 2.9% |
21.4% |
48.5% |
SENSEX | -1.4% |
0.7% |
2.4% |
You may also like the below Video Courses